Ligand Pharmaceuticals Inc
LGND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000886163
In the last 90 days, Ligand Pharmaceuticals Inc insiders filed 0 open-market purchases and 6 sales; 417 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Ligand Pharmaceuticals Inc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 212
- −16 vs. Q1 2021
- Shares held
- 15.9M
- +509.1K (+3.3%) vs. Q1 2021
- Total value
- $2.09B
- −$261.9M (−11.1%) vs. Q1 2021
- New holders
- 19
- 71 more added
- Sold out
- 35
- 77 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 417 | $7.15B |
| Q1 2026 | 359 | $4.15B |
| Q4 2025 | 351 | $3.89B |
| Q3 2025 | 314 | $3.63B |
| Q2 2025 | 271 | $2.18B |
| Q1 2025 | 262 | $1.97B |
| Q4 2024 | 259 | $1.96B |
| Q3 2024 | 243 | $1.81B |
| Q2 2024 | 235 | $1.45B |
| Q1 2024 | 222 | $1.21B |
| Q4 2023 | 211 | $1.15B |
| Q3 2023 | 197 | $946.5M |
| Q2 2023 | 204 | $1.12B |
| Q1 2023 | 213 | $1.10B |
| Q4 2022 | 198 | $983.5M |
| Q3 2022 | 205 | $1.28B |
| Q2 2022 | 198 | $1.33B |
| Q1 2022 | 207 | $1.76B |
| Q4 2021 | 221 | $2.51B |
| Q3 2021 | 208 | $2.29B |
| Q2 2021 | 212 | $2.09B |
| Q1 2021 | 228 | $2.35B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Ligand Pharmaceuticals Inc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rice Hall James & Associates, LLC | 378,726 | $49.7M | 1.77% | −51,330−11.9% | Reduced |
| Standard Life Aberdeen plc | 405,776 | $53.2M | 0.12% | +231,294+132.6% | Added |
| Dimensional Fund Advisors LP | 409,377 | $53.7M | 0.02% | +47,120+13.0% | Added |
| Conestoga Capital Advisors, LLC | 440,802 | $57.8M | 0.84% | −55,079−11.1% | Reduced |
| Chicago Capital, LLC | 458,955 | $60.2M | 2.35% | +10,318+2.3% | Added |
| Macquarie Group Ltd | 593,698 | $77.9M | 0.06% | +109,340+22.6% | Added |
| Villere St Denis J & Co LLC | 594,380 | $78.0M | 4.18% | +57,352+10.7% | Added |
| State Street Corp | 859,448 | $112.8M | 0.01% | +76,688+9.8% | Added |
| William Blair Investment Management, LLC | 1,246,452 | $163.5M | 0.51% | −44,802−3.5% | Reduced |
| Janus Henderson Group PLC | 1,444,221 | $189.5M | 0.08% | +186,424+14.8% | Added |
| Vanguard Group Inc | 1,524,155 | $200.0M | 0.00% | +5,913+0.4% | Added |
| BlackRock Inc. | 2,044,378 | $268.2M | 0.01% | −82,005−3.9% | Reduced |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −29,400−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −22,872−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −9,472−100.0% | Sold out |
| Mackay Shields LLC | 0 | $0 | 0.00% | −8,921−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −6,377−100.0% | Sold out |
| South Dakota Investment Council | 0 | $0 | 0.00% | −5,026−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −4,589−100.0% | Sold out |
| Public Sector Pension Investment Board | 0 | $0 | 0.00% | −3,648−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −3,343−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −3,333−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −2,505−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −2,509−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −1,938−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −1,784−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −1,658−100.0% | Sold out |
| BTC Capital Management, Inc. | 0 | $0 | 0.00% | −1,525−100.0% | Sold out |
| Brighton Jones LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Crossmark Global Holdings, Inc. | 0 | $0 | 0.00% | −1,446−100.0% | Sold out |
| Pictet Asset Management Ltd | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −1,353−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −1,330−100.0% | Sold out |
| Spouting Rock Asset Management, LLC | 0 | $0 | 0.00% | −1,321−100.0% | Sold out |
| NWK Group, Inc. | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −236−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −298−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Cullen/Frost Bankers, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| RWM Asset Management, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |